CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency. The purpose of this amendment is to authorize administration of COVID-19 vaccines with a FDA Emergency Use Authorization (EUA) status, without regard to the state's limitation on coverage of experimental procedures or services. This SPA also authorizes COVID drug treatments that may be provided under EUA without regard to rebate status.
State
Topics
Approval Date
Effective Date
File 1 - Approval Document Media